Click any tag below to further narrow down your results
+ protein design
(2)
+ gpt rosalind
(2)
+ molecular design
(1)
+ rosalind workbench
(1)
+ optimization
(1)
+ simulation
(1)
+ performance engineering
(1)
+ reinforcement learning
(1)
+ weakly electric fish
(1)
+ ai
(1)
+ clinical trials
(1)
+ codonroberta
(1)
+ drug targets
(1)
+ protein folding
(1)
+ genomics
(1)
Links
OpenAI released Rosalind Workbench, a unified environment that consolidates fragmented scientific tools and data into one workspace for life science researchers. It's built on GPT-Rosalind, a specialized model for biology, and available through ChatGPT with guided workflows for tasks like protein design, genomics analysis, and molecular docking.
- Solves a real workflow problem: researchers currently juggle data in one system, analysis in another, and experimental records elsewhere, losing context between steps
- Includes specialized viewers and guided tasks (protein design, small-molecule design, genomics, experimental validation) that keep biological questions connected across different tools
- Offers two access modes—Explore mode for general questions and Research mode for complex analysis, with verified organizations able to request access now and individual access coming later
The author ported a Python simulation of weakly electric fish to C and optimized it to run at one million steps per second—a 250x speedup over the original. This enabled training RL policies for the fish in under 15 seconds while maintaining biological accuracy, demonstrating how performance engineering unlocks rapid experimentation in complex simulations.
- Ported a weakly electric fish RL simulation from Python to C, boosting speed from 4,300 to 1.85M steps/sec (250x), enabling full policy training in under 10-15 seconds on a single GPU.
- Exploiting the biological detail that sensory receptors have limited range (4-10cm vs 100cm) let them skip most fish-to-fish field calculations, fixing the main bottleneck.
- Switching from double- to single-precision floats alone gave a 30% speedup.
- Shows that fast iteration—borrowed from autonomous driving RL practices—can work even in messy, physics-heavy biological simulations, and the whole thing is only 1,200 lines of open-sourced C code.
The article argues that AI’s success in molecular design won’t cure most diseases without a deeper understanding of human biology and disease mechanisms. It calls for large-scale, causal biological measurements and better links between cellular data and clinical outcomes before AI can deliver truly transformative medicines.
- AI drug discovery has focused on molecule design, but the real bottleneck is upstream: most diseases lack a validated biological target to hit.
- 90% of clinical trials fail because they target the wrong biological mechanism, not because molecule design is too slow.
- Genuinely new drug targets have dropped from ~100 in 2015 to ~30 in 2024, while 38 targets each now have 50+ drug programs piling onto the same well-known locks.
- Fixing this requires massive causal/perturbational biology data (billions more measured cell states), not just better AI models, since current cell atlases barely scratch the surface.
OpenAI trained a new LLM, GPT-Rosalind, on 50 common biological workflows and major public databases to help researchers navigate massive genomic and protein datasets. The model links genotype to phenotype, suggests biological pathways, and prioritizes potential drug targets by leveraging mechanistic understanding.
- OpenAI's GPT-Rosalind is fine-tuned on the 50 most common biological workflows plus major public gene/protein/pathway databases
- It's designed to bridge jargon silos between biology subfields (e.g., helping a plant geneticist interpret neurobiology findings)
- Beyond summarizing data, it suggests biological pathways, links genotype to phenotype, and ranks drug targets to speed up hypothesis generation in drug discovery and synthetic biology
OpenMed developed a pipeline that transforms protein concepts into codon-optimized DNA sequences. They compared various transformer architectures for codon-level language modeling, finding CodonRoBERTa-large-v2 to outperform others in biological relevance. The project includes detailed results and runnable code for each stage.
- CodonRoBERTa-large-v2 hit perplexity 4.10 and Spearman CAI correlation 0.40 across 381,000 sequences from 25 species, beating other tested architectures.
- ModernBERT badly underperformed classic RoBERTa on codon modeling (perplexity 26.24 vs 4.01), showing that advanced NLP architectures and pretrained weights don't transfer well to biological sequence data.
- The entire training pipeline ran on just 4 A100 GPUs for a total cost of $165.